Chemical formula: C₁₇H₂₀N₄S Molecular mass: 312.432 g/mol PubChem compound: 4585
Olanzapine is an antipsychotic, antimanic and mood stabilising agent that demonstrates a broad pharmacologic profile across a number of receptor systems.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC code | Group title | Classification |
|---|---|---|
| N05AH03 | Olanzapine | N Nervous system → N05 Psycholeptics → N05A Antipsychotics → N05AH Diazepines, oxazepines and thiazepines |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Title | Information Source | Document Type | |
|---|---|---|---|
| ZYPREXA Coated tablet | European Medicines Agency (EU) | MPI, EU: SmPC | |
| ZYPREXA Powder for solution for injection | European Medicines Agency (EU) | MPI, EU: SmPC | |
| ZYPREXA Tablet / Tablet, orally disintegrating / Powder for solution for injection | FDA, National Drug Code (US) | MPI, US: SPL/PLR |
Olanzapine is an active ingredient of these brands:
Canada (CA)Croatia (HR)Cyprus (CY)Estonia (EE)Finland (FI)Japan (JP)Lithuania (LT)Poland (PL)South Africa (ZA)Turkey (TR)Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
